Bath & Body Works (NYSE:BBWI) Stock Price Down 4.1% - Should You Sell?

Key Points

• Bath & Body Works' stock price fell by 4.1%, trading at $25.20, which is a significant decline from its previous close of $26.29.
• Several analysts have recently issued mixed ratings for the stock, with a downgrade to "hold" from Wall Street Zen and a high target price of $38.00 from Telsey Advisory Group.
• The company reported quarterly earnings of $0.37 EPS, meeting consensus estimates, but faced a year-over-year revenue decline of 0.8%.

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) dropped 4.1% during mid-day trading on Friday . The stock traded as low as $25.24 and last traded at $25.20. Approximately 1,596,252 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 5,341,160 shares. The stock had previously closed at $26.29.

Analyst Upgrades and Downgrades

A number of research firms recently commented on BBWI. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a research report on Thursday, August 28th. Barclays raised their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. UBS Group decreased their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a research note on Friday, August 29th. Finally, Morgan Stanley dropped their target price on Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a research report on Friday, September 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $39.69.

Bath & Body Works Trading Down 4.0%

The stock has a market cap of $5.20 billion, a PE ratio of 7.49, a PEG ratio of 0.88 and a beta of 1.49. The business has a 50-day moving average price of $29.74 and a 200 day moving average price of $29.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company's revenue was down .8% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 23.74%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in BBWI. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in shares of Bath & Body Works during the second quarter valued at about $33,000. SVB Wealth LLC acquired a new position in Bath & Body Works during the 1st quarter valued at approximately $35,000. Geneos Wealth Management Inc. raised its holdings in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC raised its position in Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock valued at $37,000 after acquiring an additional 481 shares in the last quarter. Finally, Golden State Wealth Management LLC raised its position in shares of Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.